Synthesis and evaluation of salvinorin A analogues as kappa-opioid receptor ligands for the treatment of mood disorders.

被引：0
|
作者：
Beguin, C
Richards, MR
Liu-Chen, LY
Lee, DYW
Carlezon, WA
Cohen, BM
机构：
[1] Harvard Univ, Sch Med, McLean Hosp, Mol Pharmacol Lab, Belmont, MA 02478 USA
[2] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA
[3] McLean Hosp, HMS, Bioorgan & Nat Prod Lab, Belmont, MA 02178 USA
[4] McLean Hosp, HMS, Behav Genet Lab, Belmont, MA 02178 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 229卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
069-MEDI
引用
收藏
页码：U118 / U118
页数：1
相关论文
共 50 条
  • [31] Design and structural validation of peptide-drug conjugate ligands of the kappa-opioid receptor
    Muratspahic, Edin
    Deibler, Kristine
    Han, Jianming
    Tomasevic, Natasa
    Jadhav, Kirtikumar B.
    Olive-Marti, Aina-Leonor
    Hochrainer, Nadine
    Hellinger, Roland
    Koehbach, Johannes
    Fay, Jonathan F.
    Rahman, Mohammad Homaidur
    Hegazy, Lamees
    Craven, Timothy W.
    Varga, Balazs R.
    Bhardwaj, Gaurav
    Appourchaux, Kevin
    Majumdar, Susruta
    Muttenthaler, Markus
    Hosseinzadeh, Parisa
    Craik, David J.
    Spetea, Mariana
    Che, Tao
    Baker, David
    Gruber, Christian W.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [32] ROLE OF THE SPACER IN CONFERRING KAPPA-OPIOID RECEPTOR SELECTIVITY TO BIVALENT LIGANDS RELATED TO NORBINALTORPHIMINE
    PORTOGHESE, PS
    GARZONABURBEH, A
    NAGASE, H
    LIN, CE
    TAKEMORI, AE
    JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (04) : 1292 - 1296
  • [33] CoMFA analyses of C-2 position Salvinorin A analogs at the kappa-opioid receptor provides insights into epimer selectivity
    McGovern, Donna L.
    Mosier, Philip D.
    Roth, Bryan L.
    Westkaemper, Richard B.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 28 (07): : 612 - 625
  • [34] Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse
    Fantegrossi, WE
    Kugle, KM
    Valdes, LJ
    Koreeda, M
    Woods, JH
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 (08): : 627 - 633
  • [35] Kappa-opioid antagonists as stress resilience medications for the treatment of alcohol use disorders
    Chavkin, Charles
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 (09) : 1803 - 1804
  • [36] Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders
    E Domi
    E Barbier
    E Augier
    G Augier
    D Gehlert
    R Barchiesi
    A Thorsell
    L Holm
    M Heilig
    Neuropsychopharmacology, 2018, 43 : 1805 - 1812
  • [37] Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders
    Domi, E.
    Barbier, E.
    Augier, E.
    Augier, G.
    Gehlert, D.
    Barchiesi, R.
    Thorsell, A.
    Holm, L.
    Heilig, M.
    NEUROPSYCHOPHARMACOLOGY, 2018, 43 (09) : 1805 - 1812
  • [38] INFLUENCE OF CHRONIC LITHIUM TREATMENT UPON THE MOTIVATIONAL EFFECTS OF OPIOIDS - ALTERATION IN THE EFFECTS OF MU-OPIOID BUT NOT KAPPA-OPIOID RECEPTOR LIGANDS
    SHIPPENBERG, TS
    HERZ, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 256 (03): : 1101 - 1106
  • [39] Kappa-opioid antagonists as stress resilience medications for the treatment of alcohol use disorders
    Charles Chavkin
    Neuropsychopharmacology, 2018, 43 : 1803 - 1804
  • [40] DIFFERENTIAL BINDING DOMAINS OF PEPTIDE AND NON PEPTIDE LIGANDS IN THE CLONED RAT KAPPA-OPIOID RECEPTOR
    XUE, JC
    CHEN, CG
    ZHU, JM
    KUNAPULI, S
    DERIEL, JK
    YU, L
    LIUCHEN, LY
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (48) : 30195 - 30199
12345